

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 5.82922578 |
| 2 | DNA deamination (GO:0045006) | 5.61632315 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 5.38687068 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.78274545 |
| 5 | proteasome assembly (GO:0043248) | 4.71733454 |
| 6 | viral transcription (GO:0019083) | 4.67912317 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.65085094 |
| 8 | negative regulation of cell killing (GO:0031342) | 4.65085094 |
| 9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.62384637 |
| 10 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.54180223 |
| 11 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.51783913 |
| 12 | translational termination (GO:0006415) | 4.51584910 |
| 13 | maturation of SSU-rRNA (GO:0030490) | 4.47637711 |
| 14 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.42015665 |
| 15 | ribosomal small subunit biogenesis (GO:0042274) | 4.38641502 |
| 16 | cotranslational protein targeting to membrane (GO:0006613) | 4.36289239 |
| 17 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.33107801 |
| 18 | DNA strand elongation (GO:0022616) | 4.32468221 |
| 19 | response to peptidoglycan (GO:0032494) | 4.32396697 |
| 20 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.31893957 |
| 21 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.31893957 |
| 22 | modulation by symbiont of host immune response (GO:0052553) | 4.31893957 |
| 23 | positive regulation by symbiont of host defense response (GO:0052509) | 4.31893957 |
| 24 | modulation by symbiont of host defense response (GO:0052031) | 4.31893957 |
| 25 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.31893957 |
| 26 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.30425637 |
| 27 | protein targeting to ER (GO:0045047) | 4.30010423 |
| 28 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.21677887 |
| 29 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.20926656 |
| 30 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.17719264 |
| 31 | translational elongation (GO:0006414) | 4.16569719 |
| 32 | protein localization to endoplasmic reticulum (GO:0070972) | 4.12093027 |
| 33 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.06333846 |
| 34 | detection of other organism (GO:0098543) | 3.98795952 |
| 35 | immunoglobulin mediated immune response (GO:0016064) | 3.95847476 |
| 36 | telomere maintenance via recombination (GO:0000722) | 3.95450067 |
| 37 | ATP synthesis coupled proton transport (GO:0015986) | 3.95369970 |
| 38 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.95369970 |
| 39 | detection of bacterium (GO:0016045) | 3.95104778 |
| 40 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.90330156 |
| 41 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.87169771 |
| 42 | negative regulation of ligase activity (GO:0051352) | 3.85781228 |
| 43 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.85781228 |
| 44 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.85414600 |
| 45 | negative regulation of interleukin-12 production (GO:0032695) | 3.84339448 |
| 46 | translational initiation (GO:0006413) | 3.78455871 |
| 47 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.76264807 |
| 48 | formation of translation preinitiation complex (GO:0001731) | 3.74753268 |
| 49 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.72246827 |
| 50 | protein deneddylation (GO:0000338) | 3.70740794 |
| 51 | translation (GO:0006412) | 3.69456051 |
| 52 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.69347361 |
| 53 | DNA replication initiation (GO:0006270) | 3.69127992 |
| 54 | ribosomal large subunit biogenesis (GO:0042273) | 3.68791053 |
| 55 | DNA replication checkpoint (GO:0000076) | 3.67727540 |
| 56 | viral life cycle (GO:0019058) | 3.67377591 |
| 57 | respiratory burst (GO:0045730) | 3.66973757 |
| 58 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.66762899 |
| 59 | regulation of mast cell degranulation (GO:0043304) | 3.63766649 |
| 60 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.60619856 |
| 61 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.60619856 |
| 62 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.60417169 |
| 63 | cellular protein complex disassembly (GO:0043624) | 3.59503715 |
| 64 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.59019965 |
| 65 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.59019965 |
| 66 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.59019965 |
| 67 | * regulation of cellular amino acid metabolic process (GO:0006521) | 3.58038899 |
| 68 | cullin deneddylation (GO:0010388) | 3.57979414 |
| 69 | macrophage activation involved in immune response (GO:0002281) | 3.52448448 |
| 70 | neutrophil activation (GO:0042119) | 3.51335613 |
| 71 | mitotic recombination (GO:0006312) | 3.50069840 |
| 72 | 7-methylguanosine mRNA capping (GO:0006370) | 3.49871892 |
| 73 | granulocyte activation (GO:0036230) | 3.49319391 |
| 74 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.48816756 |
| 75 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.48775109 |
| 76 | termination of RNA polymerase III transcription (GO:0006386) | 3.48744029 |
| 77 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.48744029 |
| 78 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.46552021 |
| 79 | 7-methylguanosine RNA capping (GO:0009452) | 3.46234995 |
| 80 | RNA capping (GO:0036260) | 3.46234995 |
| 81 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.45517540 |
| 82 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.45201007 |
| 83 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.45201007 |
| 84 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.41238139 |
| 85 | NADH dehydrogenase complex assembly (GO:0010257) | 3.41238139 |
| 86 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.41238139 |
| 87 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.40662625 |
| 88 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.38587851 |
| 89 | respiratory chain complex IV assembly (GO:0008535) | 3.38329222 |
| 90 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.38109286 |
| 91 | nucleobase biosynthetic process (GO:0046112) | 3.38104475 |
| 92 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.37942846 |
| 93 | telomere maintenance via telomere lengthening (GO:0010833) | 3.37033988 |
| 94 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.35770099 |
| 95 | metallo-sulfur cluster assembly (GO:0031163) | 3.35219697 |
| 96 | iron-sulfur cluster assembly (GO:0016226) | 3.35219697 |
| 97 | CENP-A containing nucleosome assembly (GO:0034080) | 3.33926224 |
| 98 | protein complex biogenesis (GO:0070271) | 3.31517681 |
| 99 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.30888345 |
| 100 | purine nucleobase biosynthetic process (GO:0009113) | 3.30389232 |
| 101 | leukocyte aggregation (GO:0070486) | 3.28905019 |
| 102 | positive regulation of ligase activity (GO:0051351) | 3.27350695 |
| 103 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.27344003 |
| 104 | positive regulation of B cell differentiation (GO:0045579) | 3.27294674 |
| 105 | regulation of leukocyte degranulation (GO:0043300) | 3.27108246 |
| 106 | chaperone-mediated protein transport (GO:0072321) | 3.26217303 |
| 107 | oxidative phosphorylation (GO:0006119) | 3.25836014 |
| 108 | pseudouridine synthesis (GO:0001522) | 3.24250842 |
| 109 | detection of external biotic stimulus (GO:0098581) | 3.22113208 |
| 110 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.21243967 |
| 111 | myeloid cell activation involved in immune response (GO:0002275) | 3.20877103 |
| 112 | positive regulation of mast cell activation (GO:0033005) | 3.18154192 |
| 113 | cellular component biogenesis (GO:0044085) | 3.17161510 |
| 114 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.16539332 |
| 115 | B cell mediated immunity (GO:0019724) | 3.16286324 |
| 116 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.15554291 |
| 117 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.14886762 |
| 118 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.14666814 |
| 119 | chromatin remodeling at centromere (GO:0031055) | 3.13515053 |
| 120 | protein complex disassembly (GO:0043241) | 3.13233554 |
| 121 | peptidyl-histidine modification (GO:0018202) | 3.11341690 |
| 122 | regulation of mitochondrial translation (GO:0070129) | 3.09308879 |
| 123 | spliceosomal snRNP assembly (GO:0000387) | 3.06507055 |
| 124 | rRNA processing (GO:0006364) | 3.05249507 |
| 125 | cell cycle G1/S phase transition (GO:0044843) | 3.03952213 |
| 126 | G1/S transition of mitotic cell cycle (GO:0000082) | 3.03952213 |
| 127 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.03919408 |
| 128 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.03464960 |
| 129 | response to host immune response (GO:0052572) | 3.03464960 |
| 130 | cellular extravasation (GO:0045123) | 3.02425287 |
| 131 | macromolecular complex disassembly (GO:0032984) | 3.00937538 |
| 132 | regulation of gamma-delta T cell activation (GO:0046643) | 3.00856366 |
| 133 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.00604765 |
| 134 | NIK/NF-kappaB signaling (GO:0038061) | 3.00517067 |
| 135 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.00240954 |
| 136 | rRNA modification (GO:0000154) | 2.98031551 |
| 137 | protein targeting to mitochondrion (GO:0006626) | 2.97523149 |
| 138 | viral mRNA export from host cell nucleus (GO:0046784) | 2.96533870 |
| 139 | cytochrome complex assembly (GO:0017004) | 2.95837126 |
| 140 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.95433051 |
| 141 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.95054718 |
| 142 | regulation of ligase activity (GO:0051340) | 2.94768307 |
| 143 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.93625641 |
| 144 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.93625641 |
| 145 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.92928130 |
| 146 | leukocyte degranulation (GO:0043299) | 2.90130686 |
| 147 | regulation of superoxide anion generation (GO:0032928) | 2.88192123 |
| 148 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.83745426 |
| 149 | type I interferon signaling pathway (GO:0060337) | 2.82166567 |
| 150 | cellular response to type I interferon (GO:0071357) | 2.82166567 |
| 151 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.80773076 |
| 152 | positive regulation of mast cell degranulation (GO:0043306) | 2.80773076 |
| 153 | B cell receptor signaling pathway (GO:0050853) | 2.80429100 |
| 154 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.79619515 |
| 155 | response to host (GO:0075136) | 2.79619515 |
| 156 | response to host defenses (GO:0052200) | 2.79619515 |
| 157 | pinocytosis (GO:0006907) | 2.79332862 |
| 158 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.79191482 |
| 159 | regulation of mast cell activation (GO:0033003) | 2.78754871 |
| 160 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.77126919 |
| 161 | response to type I interferon (GO:0034340) | 2.76315551 |
| 162 | regulation of defense response to virus by virus (GO:0050690) | 2.75551996 |
| 163 | detection of biotic stimulus (GO:0009595) | 2.75461624 |
| 164 | amino sugar catabolic process (GO:0046348) | 2.73719781 |
| 165 | regulation of regulated secretory pathway (GO:1903305) | 2.72682534 |
| 166 | positive thymic T cell selection (GO:0045059) | 2.72669015 |
| 167 | detection of molecule of bacterial origin (GO:0032490) | 2.69312923 |
| 168 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.69137260 |
| 169 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.66618633 |
| 170 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.64460607 |
| 171 | regulation of T cell tolerance induction (GO:0002664) | 2.64412992 |
| 172 | negative regulation of phagocytosis (GO:0050765) | 2.63383451 |
| 173 | regulation of B cell differentiation (GO:0045577) | 2.62328078 |
| 174 | microglial cell activation (GO:0001774) | 2.62262277 |
| 175 | response to muramyl dipeptide (GO:0032495) | 2.61911838 |
| 176 | macrophage activation (GO:0042116) | 2.61376607 |
| 177 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.61329232 |
| 178 | actin nucleation (GO:0045010) | 2.61006558 |
| 179 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.59698011 |
| 180 | T cell migration (GO:0072678) | 2.59687476 |
| 181 | negative regulation of innate immune response (GO:0045824) | 2.58443566 |
| 182 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.58020756 |
| 183 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.57056054 |
| 184 | myeloid dendritic cell activation (GO:0001773) | 2.55303292 |
| 185 | defense response to protozoan (GO:0042832) | 2.54827189 |
| 186 | lipoxygenase pathway (GO:0019372) | 2.53808099 |
| 187 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.51867269 |
| 188 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.51867269 |
| 189 | regulation of platelet aggregation (GO:0090330) | 2.51745019 |
| 190 | phagosome maturation (GO:0090382) | 2.51525191 |
| 191 | barbed-end actin filament capping (GO:0051016) | 2.51500293 |
| 192 | myeloid dendritic cell differentiation (GO:0043011) | 2.51316902 |
| 193 | modulation by virus of host process (GO:0019054) | 2.49984792 |
| 194 | regulation of tolerance induction (GO:0002643) | 2.49522387 |
| 195 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.45957509 |
| 196 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.45950778 |
| 197 | regulation of antigen processing and presentation (GO:0002577) | 2.45486929 |
| 198 | germinal center formation (GO:0002467) | 2.44615364 |
| 199 | pentose-phosphate shunt (GO:0006098) | 2.44097284 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.72606016 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.21203713 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.16982454 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.91811636 |
| 5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.83372694 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.72572658 |
| 7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.70435289 |
| 8 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.55874526 |
| 9 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.36383754 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.35415269 |
| 11 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.07983301 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.05913064 |
| 13 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.01252935 |
| 14 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.01100399 |
| 15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.93276387 |
| 16 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.69781349 |
| 17 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.64446808 |
| 18 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.61390743 |
| 19 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.60965271 |
| 20 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.55134428 |
| 21 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.54598023 |
| 22 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.54329912 |
| 23 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.53543666 |
| 24 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.50131632 |
| 25 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.37730580 |
| 26 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.37040009 |
| 27 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.31484905 |
| 28 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.29529409 |
| 29 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.27940245 |
| 30 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 2.27875594 |
| 31 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.23999522 |
| 32 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.18684938 |
| 33 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.18311959 |
| 34 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.15088613 |
| 35 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.11570646 |
| 36 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.11444806 |
| 37 | * GABP_19822575_ChIP-Seq_HepG2_Human | 2.10627205 |
| 38 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.09094360 |
| 39 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.07220901 |
| 40 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.05733264 |
| 41 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.02230542 |
| 42 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.01713936 |
| 43 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.01009175 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.96757718 |
| 45 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.94224664 |
| 46 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.94204906 |
| 47 | * MAF_26560356_Chip-Seq_TH1_Human | 1.94179718 |
| 48 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.94089233 |
| 49 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.93817523 |
| 50 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.93777967 |
| 51 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.88016529 |
| 52 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.87267099 |
| 53 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.84634069 |
| 54 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.83066529 |
| 55 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.83021364 |
| 56 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.76819638 |
| 57 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.73769054 |
| 58 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.71546275 |
| 59 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.71113535 |
| 60 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.70450480 |
| 61 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.70302182 |
| 62 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.69070939 |
| 63 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.65706159 |
| 64 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.64743345 |
| 65 | * MAF_26560356_Chip-Seq_TH2_Human | 1.64084902 |
| 66 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.63413554 |
| 67 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.63399085 |
| 68 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.63341026 |
| 69 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.61618146 |
| 70 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.59100601 |
| 71 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.57303884 |
| 72 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.54417877 |
| 73 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.54307805 |
| 74 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52961492 |
| 75 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.52360615 |
| 76 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.48211009 |
| 77 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.47986071 |
| 78 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.47918405 |
| 79 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.47388449 |
| 80 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.46674017 |
| 81 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.46492568 |
| 82 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.46407930 |
| 83 | MYB_26560356_Chip-Seq_TH2_Human | 1.44420255 |
| 84 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.44067726 |
| 85 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.41944815 |
| 86 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.41720056 |
| 87 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.40552810 |
| 88 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.40128229 |
| 89 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.40035036 |
| 90 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.37947450 |
| 91 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36484819 |
| 92 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.36481588 |
| 93 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36109864 |
| 94 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35408656 |
| 95 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.35245720 |
| 96 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.35012546 |
| 97 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.33308822 |
| 98 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32342920 |
| 99 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.31590400 |
| 100 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.31386122 |
| 101 | MYB_26560356_Chip-Seq_TH1_Human | 1.30577449 |
| 102 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.30377185 |
| 103 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.29340080 |
| 104 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.28974079 |
| 105 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.28896810 |
| 106 | P68_20966046_ChIP-Seq_HELA_Human | 1.28297431 |
| 107 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.26868983 |
| 108 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.26682090 |
| 109 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.25793633 |
| 110 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.24828165 |
| 111 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.23484751 |
| 112 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.22237281 |
| 113 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21666842 |
| 114 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.21455695 |
| 115 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.21241719 |
| 116 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.18410493 |
| 117 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.15632976 |
| 118 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.14561591 |
| 119 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.14254421 |
| 120 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13965561 |
| 121 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.11202621 |
| 122 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.09751898 |
| 123 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.09707713 |
| 124 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.09655574 |
| 125 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.09285296 |
| 126 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.08481427 |
| 127 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08307514 |
| 128 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08098656 |
| 129 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.07832860 |
| 130 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.07753052 |
| 131 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.07129396 |
| 132 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.06621386 |
| 133 | * MYC_22102868_ChIP-Seq_BL_Human | 1.06512211 |
| 134 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.05134027 |
| 135 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.04079477 |
| 136 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02100947 |
| 137 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01496020 |
| 138 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.00535579 |
| 139 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.99090388 |
| 140 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.98975144 |
| 141 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.98627624 |
| 142 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.97928951 |
| 143 | * TFEB_21752829_ChIP-Seq_HELA_Human | 0.97106174 |
| 144 | * HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.96897398 |
| 145 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.96682489 |
| 146 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.95437117 |
| 147 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.93626860 |
| 148 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.93552610 |
| 149 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.93464229 |
| 150 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91821797 |
| 151 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.90469669 |
| 152 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.89293646 |
| 153 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.89148447 |
| 154 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.88943202 |
| 155 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.87888296 |
| 156 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.86000972 |
| 157 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.85453777 |
| 158 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.83872278 |
| 159 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.81408951 |
| 160 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.80993662 |
| 161 | * EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.80245892 |
| 162 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.79192471 |
| 163 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.78752142 |
| 164 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.78255261 |
| 165 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.78053281 |
| 166 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.75251683 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 5.11957570 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 3.66177253 |
| 3 | MP0003303_peritoneal_inflammation | 3.53678514 |
| 4 | MP0010094_abnormal_chromosome_stability | 3.49514063 |
| 5 | MP0003111_abnormal_nucleus_morphology | 3.24263176 |
| 6 | MP0003077_abnormal_cell_cycle | 3.22704033 |
| 7 | MP0005058_abnormal_lysosome_morphology | 3.21462255 |
| 8 | MP0008057_abnormal_DNA_replication | 3.04659601 |
| 9 | MP0008058_abnormal_DNA_repair | 2.91334654 |
| 10 | MP0002396_abnormal_hematopoietic_system | 2.64467871 |
| 11 | MP0009379_abnormal_foot_pigmentation | 2.60980096 |
| 12 | MP0006082_CNS_inflammation | 2.55845624 |
| 13 | MP0005451_abnormal_body_composition | 2.38478608 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.38009850 |
| 15 | MP0008007_abnormal_cellular_replicative | 2.34486617 |
| 16 | MP0003186_abnormal_redox_activity | 2.34130197 |
| 17 | MP0003763_abnormal_thymus_physiology | 2.28551189 |
| 18 | MP0006036_abnormal_mitochondrial_physio | 2.25444439 |
| 19 | MP0008932_abnormal_embryonic_tissue | 2.21862002 |
| 20 | MP0003172_abnormal_lysosome_physiology | 2.16598011 |
| 21 | MP0009333_abnormal_splenocyte_physiolog | 2.11393408 |
| 22 | MP0003300_gastrointestinal_ulcer | 2.08736562 |
| 23 | MP0001835_abnormal_antigen_presentation | 1.98191233 |
| 24 | MP0000490_abnormal_crypts_of | 1.96165956 |
| 25 | MP0003656_abnormal_erythrocyte_physiolo | 1.92446720 |
| 26 | MP0001533_abnormal_skeleton_physiology | 1.92268041 |
| 27 | MP0009278_abnormal_bone_marrow | 1.88714747 |
| 28 | MP0004147_increased_porphyrin_level | 1.85358030 |
| 29 | MP0003075_altered_response_to | 1.84124491 |
| 30 | MP0009840_abnormal_foam_cell | 1.82090071 |
| 31 | MP0002132_abnormal_respiratory_system | 1.81437275 |
| 32 | MP0009785_altered_susceptibility_to | 1.80447066 |
| 33 | MP0005671_abnormal_response_to | 1.77350811 |
| 34 | MP0004947_skin_inflammation | 1.75776265 |
| 35 | MP0003786_premature_aging | 1.73243089 |
| 36 | MP0004510_myositis | 1.71203209 |
| 37 | MP0005075_abnormal_melanosome_morpholog | 1.61659087 |
| 38 | MP0002398_abnormal_bone_marrow | 1.59457624 |
| 39 | MP0001529_abnormal_vocalization | 1.58906671 |
| 40 | MP0003806_abnormal_nucleotide_metabolis | 1.56883699 |
| 41 | MP0003724_increased_susceptibility_to | 1.55975475 |
| 42 | MP0002638_abnormal_pupillary_reflex | 1.55425760 |
| 43 | MP0008260_abnormal_autophagy | 1.53357419 |
| 44 | MP0001853_heart_inflammation | 1.52003799 |
| 45 | MP0003718_maternal_effect | 1.51822031 |
| 46 | MP0008877_abnormal_DNA_methylation | 1.49784678 |
| 47 | MP0001986_abnormal_taste_sensitivity | 1.48648755 |
| 48 | MP0000689_abnormal_spleen_morphology | 1.46883830 |
| 49 | MP0002722_abnormal_immune_system | 1.45483621 |
| 50 | MP0008004_abnormal_stomach_pH | 1.41505009 |
| 51 | MP0005397_hematopoietic_system_phenotyp | 1.40481767 |
| 52 | MP0001545_abnormal_hematopoietic_system | 1.40481767 |
| 53 | MP0002019_abnormal_tumor_incidence | 1.40220455 |
| 54 | MP0009764_decreased_sensitivity_to | 1.39987849 |
| 55 | MP0002148_abnormal_hypersensitivity_rea | 1.38082962 |
| 56 | MP0000685_abnormal_immune_system | 1.36845819 |
| 57 | MP0002429_abnormal_blood_cell | 1.35693485 |
| 58 | MP0000313_abnormal_cell_death | 1.32224322 |
| 59 | MP0002420_abnormal_adaptive_immunity | 1.32224195 |
| 60 | MP0005025_abnormal_response_to | 1.31320848 |
| 61 | MP0000604_amyloidosis | 1.30080978 |
| 62 | MP0001819_abnormal_immune_cell | 1.29049464 |
| 63 | MP0003828_pulmonary_edema | 1.29036901 |
| 64 | MP0003123_paternal_imprinting | 1.28785908 |
| 65 | MP0000716_abnormal_immune_system | 1.28595197 |
| 66 | MP0006035_abnormal_mitochondrial_morpho | 1.26543389 |
| 67 | MP0000350_abnormal_cell_proliferation | 1.25426920 |
| 68 | MP0002998_abnormal_bone_remodeling | 1.24815357 |
| 69 | MP0008789_abnormal_olfactory_epithelium | 1.24510226 |
| 70 | MP0002163_abnormal_gland_morphology | 1.24027915 |
| 71 | MP0005166_decreased_susceptibility_to | 1.22888426 |
| 72 | MP0002877_abnormal_melanocyte_morpholog | 1.22093588 |
| 73 | MP0000703_abnormal_thymus_morphology | 1.21725965 |
| 74 | MP0000372_irregular_coat_pigmentation | 1.21166639 |
| 75 | MP0000858_altered_metastatic_potential | 1.20743586 |
| 76 | MP0006054_spinal_hemorrhage | 1.19736840 |
| 77 | MP0005000_abnormal_immune_tolerance | 1.19528487 |
| 78 | MP0001730_embryonic_growth_arrest | 1.19118725 |
| 79 | MP0001800_abnormal_humoral_immune | 1.19050190 |
| 80 | MP0001764_abnormal_homeostasis | 1.18988691 |
| 81 | MP0002723_abnormal_immune_serum | 1.18455755 |
| 82 | MP0004808_abnormal_hematopoietic_stem | 1.16338040 |
| 83 | MP0000358_abnormal_cell_content/ | 1.16187055 |
| 84 | MP0006292_abnormal_olfactory_placode | 1.15500949 |
| 85 | MP0003866_abnormal_defecation | 1.13137267 |
| 86 | MP0001905_abnormal_dopamine_level | 1.12471004 |
| 87 | MP0005310_abnormal_salivary_gland | 1.12355458 |
| 88 | MP0002452_abnormal_antigen_presenting | 1.12016884 |
| 89 | MP0002405_respiratory_system_inflammati | 1.11468717 |
| 90 | MP0003448_altered_tumor_morphology | 1.07536110 |
| 91 | MP0005408_hypopigmentation | 1.05877678 |
| 92 | MP0009763_increased_sensitivity_to | 1.02397460 |
| 93 | MP0003183_abnormal_peptide_metabolism | 1.01903951 |
| 94 | MP0001851_eye_inflammation | 1.00998427 |
| 95 | MP0002095_abnormal_skin_pigmentation | 0.98891672 |
| 96 | MP0005174_abnormal_tail_pigmentation | 0.97591134 |
| 97 | MP0002160_abnormal_reproductive_system | 0.95360971 |
| 98 | MP0001873_stomach_inflammation | 0.93789026 |
| 99 | MP0003329_amyloid_beta_deposits | 0.93221094 |
| 100 | MP0001663_abnormal_digestive_system | 0.92635739 |
| 101 | MP0002938_white_spotting | 0.91529190 |
| 102 | MP0002419_abnormal_innate_immunity | 0.90950786 |
| 103 | MP0008874_decreased_physiological_sensi | 0.90120750 |
| 104 | MP0005636_abnormal_mineral_homeostasis | 0.88882761 |
| 105 | MP0004858_abnormal_nervous_system | 0.87142176 |
| 106 | MP0002080_prenatal_lethality | 0.86457652 |
| 107 | MP0003453_abnormal_keratinocyte_physiol | 0.86210203 |
| 108 | MP0002653_abnormal_ependyma_morphology | 0.85900655 |
| 109 | MP0005165_increased_susceptibility_to | 0.85240093 |
| 110 | MP0000465_gastrointestinal_hemorrhage | 0.84902483 |
| 111 | MP0000015_abnormal_ear_pigmentation | 0.84574271 |
| 112 | MP0005390_skeleton_phenotype | 0.84564624 |
| 113 | MP0003646_muscle_fatigue | 0.82240107 |
| 114 | MP0005083_abnormal_biliary_tract | 0.81862405 |
| 115 | MP0001697_abnormal_embryo_size | 0.80992502 |
| 116 | MP0003436_decreased_susceptibility_to | 0.80473346 |
| 117 | MP0003705_abnormal_hypodermis_morpholog | 0.78227327 |
| 118 | MP0002166_altered_tumor_susceptibility | 0.77815382 |
| 119 | MP0001845_abnormal_inflammatory_respons | 0.76256370 |
| 120 | MP0003795_abnormal_bone_structure | 0.75635013 |
| 121 | MP0005464_abnormal_platelet_physiology | 0.75039818 |
| 122 | MP0009697_abnormal_copulation | 0.74988590 |
| 123 | MP0003566_abnormal_cell_adhesion | 0.74467183 |
| 124 | MP0002210_abnormal_sex_determination | 0.73957512 |
| 125 | MP0001790_abnormal_immune_system | 0.72828963 |
| 126 | MP0005387_immune_system_phenotype | 0.72828963 |
| 127 | MP0003690_abnormal_glial_cell | 0.72224853 |
| 128 | MP0003315_abnormal_perineum_morphology | 0.71990201 |
| 129 | MP0004883_abnormal_blood_vessel | 0.71740867 |
| 130 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.71340413 |
| 131 | MP0003221_abnormal_cardiomyocyte_apopto | 0.70519348 |
| 132 | MP0001542_abnormal_bone_strength | 0.70507412 |
| 133 | MP0005379_endocrine/exocrine_gland_phen | 0.69973746 |
| 134 | MP0003567_abnormal_fetal_cardiomyocyte | 0.69192924 |
| 135 | MP0008469_abnormal_protein_level | 0.69116982 |
| 136 | MP0005319_abnormal_enzyme/_coenzyme | 0.68374385 |
| 137 | MP0001119_abnormal_female_reproductive | 0.68240233 |
| 138 | MP0009765_abnormal_xenobiotic_induced | 0.67882445 |
| 139 | MP0000343_altered_response_to | 0.66156574 |
| 140 | MP0002751_abnormal_autonomic_nervous | 0.66012489 |
| 141 | MP0005164_abnormal_response_to | 0.64511839 |
| 142 | MP0005266_abnormal_metabolism | 0.64505953 |
| 143 | MP0010155_abnormal_intestine_physiology | 0.64460114 |
| 144 | MP0002006_tumorigenesis | 0.63474033 |
| 145 | MP0004185_abnormal_adipocyte_glucose | 0.61490420 |
| 146 | MP0000249_abnormal_blood_vessel | 0.60517118 |
| 147 | MP0005381_digestive/alimentary_phenotyp | 0.55782214 |
| 148 | MP0004381_abnormal_hair_follicle | 0.55567958 |
| 149 | MP0002332_abnormal_exercise_endurance | 0.55494104 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.15966881 |
| 2 | Eczematoid dermatitis (HP:0000976) | 5.06869386 |
| 3 | Abnormal number of erythroid precursors (HP:0012131) | 5.03451938 |
| 4 | Abnormality of macrophages (HP:0004311) | 4.95459496 |
| 5 | Recurrent abscess formation (HP:0002722) | 4.84566776 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 4.63215709 |
| 7 | Acute necrotizing encephalopathy (HP:0006965) | 4.50181630 |
| 8 | Hepatocellular necrosis (HP:0001404) | 4.38881686 |
| 9 | Mitochondrial inheritance (HP:0001427) | 4.36274142 |
| 10 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.30410187 |
| 11 | Hepatic necrosis (HP:0002605) | 4.16468311 |
| 12 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.14111539 |
| 13 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.14111539 |
| 14 | Aplastic anemia (HP:0001915) | 4.12274801 |
| 15 | Chronic obstructive pulmonary disease (HP:0006510) | 4.09156708 |
| 16 | Obstructive lung disease (HP:0006536) | 4.09156708 |
| 17 | Abnormality of glycolipid metabolism (HP:0010969) | 4.06178287 |
| 18 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.06178287 |
| 19 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.06178287 |
| 20 | Increased CSF lactate (HP:0002490) | 3.98050366 |
| 21 | Reticulocytopenia (HP:0001896) | 3.89193056 |
| 22 | Purpura (HP:0000979) | 3.71422880 |
| 23 | Type I transferrin isoform profile (HP:0003642) | 3.71211962 |
| 24 | Myositis (HP:0100614) | 3.63366807 |
| 25 | Acute encephalopathy (HP:0006846) | 3.61936561 |
| 26 | Prolonged bleeding time (HP:0003010) | 3.57637749 |
| 27 | Mediastinal lymphadenopathy (HP:0100721) | 3.51426413 |
| 28 | Progressive macrocephaly (HP:0004481) | 3.45771483 |
| 29 | Increased hepatocellular lipid droplets (HP:0006565) | 3.42904207 |
| 30 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.41611261 |
| 31 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.40765756 |
| 32 | Increased serum lactate (HP:0002151) | 3.30276948 |
| 33 | Stomatitis (HP:0010280) | 3.29373282 |
| 34 | Increased cerebral lipofuscin (HP:0011813) | 3.26376139 |
| 35 | Birth length less than 3rd percentile (HP:0003561) | 3.24840037 |
| 36 | Lipid accumulation in hepatocytes (HP:0006561) | 3.15716565 |
| 37 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.14239427 |
| 38 | Hepatosplenomegaly (HP:0001433) | 3.12711171 |
| 39 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.12165811 |
| 40 | Orchitis (HP:0100796) | 3.11173794 |
| 41 | 3-Methylglutaconic aciduria (HP:0003535) | 3.10020596 |
| 42 | Meningitis (HP:0001287) | 3.08374267 |
| 43 | Macrocytic anemia (HP:0001972) | 3.06446298 |
| 44 | Exertional dyspnea (HP:0002875) | 3.05119762 |
| 45 | Recurrent fungal infections (HP:0002841) | 2.98954673 |
| 46 | Increased intramyocellular lipid droplets (HP:0012240) | 2.98882057 |
| 47 | Oral leukoplakia (HP:0002745) | 2.98676415 |
| 48 | Cellulitis (HP:0100658) | 2.98285520 |
| 49 | Epistaxis (HP:0000421) | 2.97524970 |
| 50 | Reduced antithrombin III activity (HP:0001976) | 2.95622294 |
| 51 | Dysostosis multiplex (HP:0000943) | 2.93823138 |
| 52 | Urticaria (HP:0001025) | 2.93491012 |
| 53 | Increased serum ferritin (HP:0003281) | 2.90555809 |
| 54 | Exercise intolerance (HP:0003546) | 2.89369115 |
| 55 | Recurrent skin infections (HP:0001581) | 2.89036481 |
| 56 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.88034964 |
| 57 | Lactic acidosis (HP:0003128) | 2.87439720 |
| 58 | IgM deficiency (HP:0002850) | 2.84500920 |
| 59 | Cerebral hypomyelination (HP:0006808) | 2.83084802 |
| 60 | Respiratory difficulties (HP:0002880) | 2.82346138 |
| 61 | Spontaneous hematomas (HP:0007420) | 2.81439797 |
| 62 | Pallor (HP:0000980) | 2.81064896 |
| 63 | Vacuolated lymphocytes (HP:0001922) | 2.79913223 |
| 64 | Abnormal protein glycosylation (HP:0012346) | 2.77920500 |
| 65 | Abnormal glycosylation (HP:0012345) | 2.77920500 |
| 66 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.77920500 |
| 67 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.77920500 |
| 68 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.76950003 |
| 69 | Renal Fanconi syndrome (HP:0001994) | 2.76706286 |
| 70 | Gastrointestinal infarctions (HP:0005244) | 2.72408584 |
| 71 | Respiratory failure (HP:0002878) | 2.70710434 |
| 72 | Loss of speech (HP:0002371) | 2.70624992 |
| 73 | Thrombocytosis (HP:0001894) | 2.69882302 |
| 74 | Increased serum pyruvate (HP:0003542) | 2.66644116 |
| 75 | Abnormality of glycolysis (HP:0004366) | 2.66644116 |
| 76 | Microretrognathia (HP:0000308) | 2.64063068 |
| 77 | Increased muscle lipid content (HP:0009058) | 2.63724181 |
| 78 | Retrobulbar optic neuritis (HP:0100654) | 2.62174223 |
| 79 | Optic neuritis (HP:0100653) | 2.62174223 |
| 80 | Petechiae (HP:0000967) | 2.60718366 |
| 81 | Encephalitis (HP:0002383) | 2.60138505 |
| 82 | Recurrent viral infections (HP:0004429) | 2.59931381 |
| 83 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.59448928 |
| 84 | Increased IgM level (HP:0003496) | 2.57115540 |
| 85 | Gingivitis (HP:0000230) | 2.55429798 |
| 86 | Increased IgE level (HP:0003212) | 2.54275788 |
| 87 | Degeneration of anterior horn cells (HP:0002398) | 2.51438930 |
| 88 | Abnormality of the anterior horn cell (HP:0006802) | 2.51438930 |
| 89 | Breast hypoplasia (HP:0003187) | 2.50480237 |
| 90 | Amyloidosis (HP:0011034) | 2.48814277 |
| 91 | Hypertensive crisis (HP:0100735) | 2.48365841 |
| 92 | Gingival bleeding (HP:0000225) | 2.47713465 |
| 93 | Abnormality of iron homeostasis (HP:0011031) | 2.45713389 |
| 94 | Vasculitis (HP:0002633) | 2.44275362 |
| 95 | Gastrointestinal inflammation (HP:0004386) | 2.43536909 |
| 96 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.42810683 |
| 97 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.41617649 |
| 98 | Abnormal platelet volume (HP:0011876) | 2.40504624 |
| 99 | Inflammation of the large intestine (HP:0002037) | 2.38528034 |
| 100 | Systemic lupus erythematosus (HP:0002725) | 2.38184612 |
| 101 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.36468106 |
| 102 | Recurrent cutaneous fungal infections (HP:0011370) | 2.36468106 |
| 103 | Type 2 muscle fiber atrophy (HP:0003554) | 2.31945692 |
| 104 | Muscle fiber atrophy (HP:0100295) | 2.28980732 |
| 105 | Chest pain (HP:0100749) | 2.26798266 |
| 106 | Progressive neurologic deterioration (HP:0002344) | 2.23326767 |
| 107 | Microvesicular hepatic steatosis (HP:0001414) | 2.22672272 |
| 108 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.18150540 |
| 109 | Poor head control (HP:0002421) | 2.17713079 |
| 110 | Colitis (HP:0002583) | 2.17508630 |
| 111 | Severe visual impairment (HP:0001141) | 2.16326198 |
| 112 | Cerebral edema (HP:0002181) | 2.16227257 |
| 113 | Optic disc pallor (HP:0000543) | 2.16184856 |
| 114 | Pancytopenia (HP:0001876) | 2.14558031 |
| 115 | Episodic fever (HP:0001954) | 2.14478771 |
| 116 | Ragged-red muscle fibers (HP:0003200) | 2.12541585 |
| 117 | Vertebral compression fractures (HP:0002953) | 2.12020482 |
| 118 | Granulocytopenia (HP:0001913) | 2.11115091 |
| 119 | Hypergammaglobulinemia (HP:0010702) | 2.11024396 |
| 120 | Impaired platelet aggregation (HP:0003540) | 2.10108897 |
| 121 | Abnormal platelet function (HP:0011869) | 2.10108897 |
| 122 | 11 pairs of ribs (HP:0000878) | 2.09415719 |
| 123 | Rough bone trabeculation (HP:0100670) | 2.09180803 |
| 124 | Pulmonary infiltrates (HP:0002113) | 2.08478348 |
| 125 | Pustule (HP:0200039) | 2.07065531 |
| 126 | T lymphocytopenia (HP:0005403) | 2.06029658 |
| 127 | Cholecystitis (HP:0001082) | 2.03859915 |
| 128 | Abnormal gallbladder physiology (HP:0012438) | 2.03859915 |
| 129 | Carpal bone hypoplasia (HP:0001498) | 2.03077676 |
| 130 | Osteomyelitis (HP:0002754) | 2.02659607 |
| 131 | Agammaglobulinemia (HP:0004432) | 2.01345419 |
| 132 | Polycythemia (HP:0001901) | 2.00706567 |
| 133 | Leukodystrophy (HP:0002415) | 1.99535910 |
| 134 | CNS demyelination (HP:0007305) | 1.99516733 |
| 135 | Emotional lability (HP:0000712) | 1.98580971 |
| 136 | Gastrointestinal stroma tumor (HP:0100723) | 1.98477227 |
| 137 | Hypochromic anemia (HP:0001931) | 1.98025787 |
| 138 | Distal lower limb muscle weakness (HP:0009053) | 1.96591882 |
| 139 | Autoimmune thrombocytopenia (HP:0001973) | 1.95436697 |
| 140 | Generalized aminoaciduria (HP:0002909) | 1.95317277 |
| 141 | Menorrhagia (HP:0000132) | 1.95016195 |
| 142 | Abnormality of alanine metabolism (HP:0010916) | 1.93422897 |
| 143 | Hyperalaninemia (HP:0003348) | 1.93422897 |
| 144 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.93422897 |
| 145 | Anorexia (HP:0002039) | 1.93084277 |
| 146 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.92882095 |
| 147 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.92882095 |
| 148 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.92882095 |
| 149 | Abnormality of T cells (HP:0002843) | 1.92823353 |
| 150 | Interstitial pulmonary disease (HP:0006530) | 1.91430776 |
| 151 | Increased mean platelet volume (HP:0011877) | 1.89640183 |
| 152 | Abnormality of T cell number (HP:0011839) | 1.89500434 |
| 153 | Slow saccadic eye movements (HP:0000514) | 1.89200663 |
| 154 | Leukocytosis (HP:0001974) | 1.89110004 |
| 155 | Keratoconjunctivitis sicca (HP:0001097) | 1.88965848 |
| 156 | Microcytic anemia (HP:0001935) | 1.88932383 |
| 157 | Panhypogammaglobulinemia (HP:0003139) | 1.88804877 |
| 158 | Upper motor neuron abnormality (HP:0002127) | 1.88327079 |
| 159 | IgG deficiency (HP:0004315) | 1.87490418 |
| 160 | Hypochromic microcytic anemia (HP:0004840) | 1.87326797 |
| 161 | Hemoptysis (HP:0002105) | 1.87255931 |
| 162 | Axonal loss (HP:0003447) | 1.86812501 |
| 163 | Abnormality of the preputium (HP:0100587) | 1.86297004 |
| 164 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85471753 |
| 165 | Neuronal loss in central nervous system (HP:0002529) | 1.85441641 |
| 166 | Premature graying of hair (HP:0002216) | 1.84531176 |
| 167 | Hypertriglyceridemia (HP:0002155) | 1.83720419 |
| 168 | Glomerulopathy (HP:0100820) | 1.83526880 |
| 169 | Lymphopenia (HP:0001888) | 1.83222121 |
| 170 | Bone marrow hypocellularity (HP:0005528) | 1.82209435 |
| 171 | Multiple enchondromatosis (HP:0005701) | 1.81436015 |
| 172 | Patellar aplasia (HP:0006443) | 1.80576639 |
| 173 | Lymphoma (HP:0002665) | 1.79935025 |
| 174 | Colon cancer (HP:0003003) | 1.79555541 |
| 175 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.79185524 |
| 176 | Pulmonary fibrosis (HP:0002206) | 1.78092306 |
| 177 | Hypothermia (HP:0002045) | 1.77857651 |
| 178 | Chronic otitis media (HP:0000389) | 1.77436179 |
| 179 | Neutropenia (HP:0001875) | 1.77253840 |
| 180 | B lymphocytopenia (HP:0010976) | 1.76998839 |
| 181 | Abnormality of B cell number (HP:0010975) | 1.76998839 |
| 182 | Abnormal lung lobation (HP:0002101) | 1.76719901 |
| 183 | Secondary amenorrhea (HP:0000869) | 1.76069343 |
| 184 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.74899161 |
| 185 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.74301786 |
| 186 | Abnormality of T cell physiology (HP:0011840) | 1.74263739 |
| 187 | Unsteady gait (HP:0002317) | 1.71872116 |
| 188 | Meckel diverticulum (HP:0002245) | 1.70817955 |
| 189 | CNS hypomyelination (HP:0003429) | 1.69925899 |
| 190 | Abnormality of the ileum (HP:0001549) | 1.67729098 |
| 191 | Glycosuria (HP:0003076) | 1.64872186 |
| 192 | Abnormality of urine glucose concentration (HP:0011016) | 1.64872186 |
| 193 | Female pseudohermaphroditism (HP:0010458) | 1.64739639 |
| 194 | Myelodysplasia (HP:0002863) | 1.64540232 |
| 195 | Cellular immunodeficiency (HP:0005374) | 1.62936785 |
| 196 | Pancreatic cysts (HP:0001737) | 1.62098871 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.40299963 |
| 2 | RIPK4 | 4.10056584 |
| 3 | STK16 | 4.08279595 |
| 4 | NME2 | 3.58913119 |
| 5 | EIF2AK1 | 3.33005485 |
| 6 | EIF2AK3 | 3.16354474 |
| 7 | ERN1 | 3.10075265 |
| 8 | WEE1 | 2.81402867 |
| 9 | PRPF4B | 2.62172763 |
| 10 | VRK1 | 2.43619247 |
| 11 | CDC7 | 2.37042680 |
| 12 | PIM2 | 2.33472891 |
| 13 | TESK2 | 2.18119822 |
| 14 | SRPK1 | 2.01927162 |
| 15 | FES | 1.90634241 |
| 16 | ARAF | 1.87817225 |
| 17 | GRK6 | 1.87798041 |
| 18 | BRSK2 | 1.85525193 |
| 19 | ACVR1B | 1.84720174 |
| 20 | SMG1 | 1.70592814 |
| 21 | CSK | 1.70340651 |
| 22 | TRIB3 | 1.69349919 |
| 23 | TAOK1 | 1.69225867 |
| 24 | KDR | 1.62060770 |
| 25 | TLK1 | 1.61550903 |
| 26 | TSSK6 | 1.56436899 |
| 27 | MAP3K12 | 1.56380501 |
| 28 | PLK4 | 1.53225997 |
| 29 | MAP4K1 | 1.51845289 |
| 30 | BRAF | 1.45525120 |
| 31 | TNK2 | 1.44027597 |
| 32 | NME1 | 1.43044504 |
| 33 | PASK | 1.42268013 |
| 34 | MAP2K3 | 1.37128397 |
| 35 | CCNB1 | 1.35914432 |
| 36 | RPS6KA4 | 1.35064511 |
| 37 | CDK19 | 1.30587049 |
| 38 | PBK | 1.30402673 |
| 39 | DYRK3 | 1.29290169 |
| 40 | TEC | 1.28475596 |
| 41 | MYLK | 1.27368543 |
| 42 | BRSK1 | 1.25080959 |
| 43 | MAP3K13 | 1.24018721 |
| 44 | MAP3K1 | 1.21560958 |
| 45 | CDK8 | 1.20136085 |
| 46 | MKNK1 | 1.18504662 |
| 47 | HCK | 1.18122378 |
| 48 | BCKDK | 1.16721294 |
| 49 | IRAK4 | 1.16681891 |
| 50 | FGR | 1.16310702 |
| 51 | EIF2AK2 | 1.12765698 |
| 52 | PLK1 | 1.12752115 |
| 53 | TESK1 | 1.12397342 |
| 54 | AURKB | 1.11848548 |
| 55 | AURKA | 1.11059751 |
| 56 | MAP3K14 | 1.10971680 |
| 57 | CSF1R | 1.06014714 |
| 58 | MAP3K11 | 1.06012833 |
| 59 | BTK | 1.05900837 |
| 60 | ZAP70 | 1.01609247 |
| 61 | EPHB1 | 1.00922578 |
| 62 | NEK2 | 0.98974224 |
| 63 | KIT | 0.98481495 |
| 64 | KSR2 | 0.97087164 |
| 65 | LIMK1 | 0.97017455 |
| 66 | TXK | 0.95926936 |
| 67 | SCYL2 | 0.93944821 |
| 68 | PLK3 | 0.93424669 |
| 69 | TGFBR1 | 0.92186067 |
| 70 | SIK3 | 0.89421835 |
| 71 | CDK7 | 0.88195044 |
| 72 | BMPR2 | 0.84586725 |
| 73 | ATR | 0.84428446 |
| 74 | BMX | 0.84109282 |
| 75 | MST4 | 0.83738650 |
| 76 | ILK | 0.82744071 |
| 77 | BLK | 0.82639546 |
| 78 | ZAK | 0.81829063 |
| 79 | FLT3 | 0.81650066 |
| 80 | JAK2 | 0.81097686 |
| 81 | PDPK1 | 0.81025011 |
| 82 | LCK | 0.78982493 |
| 83 | MAPKAPK5 | 0.78154639 |
| 84 | MAP3K5 | 0.78153326 |
| 85 | STK10 | 0.74774549 |
| 86 | RPS6KA5 | 0.74681448 |
| 87 | RPS6KB2 | 0.74581645 |
| 88 | TTK | 0.72771541 |
| 89 | MKNK2 | 0.72020655 |
| 90 | NEK1 | 0.71132028 |
| 91 | MATK | 0.70241154 |
| 92 | NLK | 0.70072925 |
| 93 | PDK1 | 0.69551579 |
| 94 | ITK | 0.68855336 |
| 95 | ADRBK2 | 0.68849492 |
| 96 | ABL2 | 0.68501531 |
| 97 | MAPK12 | 0.67820273 |
| 98 | SYK | 0.67753003 |
| 99 | MARK3 | 0.67148972 |
| 100 | STK4 | 0.66969160 |
| 101 | CSNK2A1 | 0.66747738 |
| 102 | DYRK2 | 0.66209774 |
| 103 | PRKD2 | 0.65937531 |
| 104 | CLK1 | 0.64041521 |
| 105 | IRAK2 | 0.63968617 |
| 106 | PAK1 | 0.63440024 |
| 107 | MOS | 0.63410554 |
| 108 | TYK2 | 0.62789628 |
| 109 | LRRK2 | 0.62730926 |
| 110 | MAPKAPK3 | 0.62527383 |
| 111 | MUSK | 0.61683824 |
| 112 | SIK1 | 0.61113624 |
| 113 | CHEK2 | 0.61067000 |
| 114 | MARK2 | 0.55872663 |
| 115 | JAK1 | 0.55787619 |
| 116 | ICK | 0.55728042 |
| 117 | GRK7 | 0.55436248 |
| 118 | MAP3K8 | 0.55250281 |
| 119 | PIM1 | 0.54611013 |
| 120 | DAPK1 | 0.54197911 |
| 121 | TAOK3 | 0.54122383 |
| 122 | PAK4 | 0.53583043 |
| 123 | CSNK2A2 | 0.52960730 |
| 124 | VRK2 | 0.52451229 |
| 125 | LYN | 0.51988361 |
| 126 | IRAK3 | 0.49828420 |
| 127 | PTK6 | 0.49513386 |
| 128 | TTN | 0.49255420 |
| 129 | TGFBR2 | 0.48078830 |
| 130 | PRKCI | 0.47591253 |
| 131 | RAF1 | 0.47190458 |
| 132 | CDK4 | 0.47169719 |
| 133 | TAOK2 | 0.46164433 |
| 134 | DAPK3 | 0.45737630 |
| 135 | MAPK11 | 0.45733234 |
| 136 | TBK1 | 0.44191139 |
| 137 | IKBKE | 0.42907107 |
| 138 | CAMKK2 | 0.41922714 |
| 139 | JAK3 | 0.41484704 |
| 140 | PRKG2 | 0.41459016 |
| 141 | FYN | 0.41448582 |
| 142 | STK24 | 0.41311673 |
| 143 | EEF2K | 0.40723891 |
| 144 | IKBKB | 0.40251295 |
| 145 | HIPK2 | 0.39761033 |
| 146 | RPS6KC1 | 0.39711020 |
| 147 | RPS6KL1 | 0.39711020 |
| 148 | MAP2K6 | 0.38935006 |
| 149 | CDC42BPA | 0.38227405 |
| 150 | BMPR1B | 0.37893400 |
| 151 | GRK5 | 0.36916397 |
| 152 | CSNK1G3 | 0.36530393 |
| 153 | MAP3K3 | 0.35629158 |
| 154 | MAPKAPK2 | 0.35488467 |
| 155 | RIPK1 | 0.34734068 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.55670453 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 4.48968852 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 4.40496083 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 3.49846905 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 3.35394281 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.90644118 |
| 7 | Base excision repair_Homo sapiens_hsa03410 | 2.83259245 |
| 8 | Protein export_Homo sapiens_hsa03060 | 2.79828200 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.73172153 |
| 10 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.62940450 |
| 11 | Homologous recombination_Homo sapiens_hsa03440 | 2.61093444 |
| 12 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.59552618 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.58097715 |
| 14 | Spliceosome_Homo sapiens_hsa03040 | 2.49488177 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.31656414 |
| 16 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.28092187 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.06747433 |
| 18 | Huntingtons disease_Homo sapiens_hsa05016 | 2.02981380 |
| 19 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.00910450 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.98514283 |
| 21 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.94332555 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.90253893 |
| 23 | Lysosome_Homo sapiens_hsa04142 | 1.87195187 |
| 24 | RNA transport_Homo sapiens_hsa03013 | 1.86397556 |
| 25 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.85797399 |
| 26 | Viral myocarditis_Homo sapiens_hsa05416 | 1.83199503 |
| 27 | Cell cycle_Homo sapiens_hsa04110 | 1.81258321 |
| 28 | Basal transcription factors_Homo sapiens_hsa03022 | 1.71685362 |
| 29 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.66034792 |
| 30 | Malaria_Homo sapiens_hsa05144 | 1.63658996 |
| 31 | Alzheimers disease_Homo sapiens_hsa05010 | 1.62056630 |
| 32 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.60902731 |
| 33 | RNA degradation_Homo sapiens_hsa03018 | 1.60094526 |
| 34 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.56166593 |
| 35 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.55788850 |
| 36 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.53045162 |
| 37 | Purine metabolism_Homo sapiens_hsa00230 | 1.51792961 |
| 38 | Salmonella infection_Homo sapiens_hsa05132 | 1.48793702 |
| 39 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.48701835 |
| 40 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.39366689 |
| 41 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.38710776 |
| 42 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.38304461 |
| 43 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.37864454 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.32636713 |
| 45 | Influenza A_Homo sapiens_hsa05164 | 1.32633950 |
| 46 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.27996550 |
| 47 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.25936795 |
| 48 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.23649148 |
| 49 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.22896737 |
| 50 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.22001498 |
| 51 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.19152343 |
| 52 | Pertussis_Homo sapiens_hsa05133 | 1.18034774 |
| 53 | Sulfur relay system_Homo sapiens_hsa04122 | 1.17067920 |
| 54 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.15185412 |
| 55 | Platelet activation_Homo sapiens_hsa04611 | 1.08121482 |
| 56 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.07028038 |
| 57 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.05315544 |
| 58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.04499883 |
| 59 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.03317822 |
| 60 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.01238816 |
| 61 | Endocytosis_Homo sapiens_hsa04144 | 1.01074623 |
| 62 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.00789110 |
| 63 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.00228016 |
| 64 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.99858291 |
| 65 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.99595597 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.98226062 |
| 67 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.95528887 |
| 68 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.94417571 |
| 69 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.92927144 |
| 70 | Hepatitis B_Homo sapiens_hsa05161 | 0.90990111 |
| 71 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.88976647 |
| 72 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.86445763 |
| 73 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.86228822 |
| 74 | Bladder cancer_Homo sapiens_hsa05219 | 0.85886782 |
| 75 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.84634395 |
| 76 | Hepatitis C_Homo sapiens_hsa05160 | 0.81991024 |
| 77 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.81163771 |
| 78 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.80414729 |
| 79 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.79400736 |
| 80 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.78338072 |
| 81 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.71234327 |
| 82 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.67930865 |
| 83 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.67551150 |
| 84 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.66741910 |
| 85 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.64788289 |
| 86 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.63292450 |
| 87 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.62381254 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.62160811 |
| 89 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.61684033 |
| 90 | Metabolic pathways_Homo sapiens_hsa01100 | 0.61629311 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60325161 |
| 92 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.59028017 |
| 93 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.58577861 |
| 94 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.58215653 |
| 95 | Other glycan degradation_Homo sapiens_hsa00511 | 0.56183519 |
| 96 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.55962721 |
| 97 | Legionellosis_Homo sapiens_hsa05134 | 0.55880622 |
| 98 | Carbon metabolism_Homo sapiens_hsa01200 | 0.54463015 |
| 99 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.52488874 |
| 100 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.52232227 |
| 101 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.51609910 |
| 102 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.48619863 |
| 103 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.48311344 |
| 104 | Galactose metabolism_Homo sapiens_hsa00052 | 0.45798394 |
| 105 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.45269604 |
| 106 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44959841 |
| 107 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.44847815 |
| 108 | Thyroid cancer_Homo sapiens_hsa05216 | 0.44643914 |
| 109 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.42796707 |
| 110 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.42731163 |
| 111 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.40889442 |
| 112 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.40120245 |
| 113 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39889159 |
| 114 | Measles_Homo sapiens_hsa05162 | 0.39685931 |
| 115 | Allograft rejection_Homo sapiens_hsa05330 | 0.38747921 |
| 116 | Amoebiasis_Homo sapiens_hsa05146 | 0.37831540 |
| 117 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37072571 |
| 118 | Shigellosis_Homo sapiens_hsa05131 | 0.36469905 |
| 119 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.36456430 |
| 120 | Asthma_Homo sapiens_hsa05310 | 0.36000438 |
| 121 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.34519179 |
| 122 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.33309988 |
| 123 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.32963018 |
| 124 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.32930653 |
| 125 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.32473829 |
| 126 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.30713522 |
| 127 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30580338 |
| 128 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.30234935 |
| 129 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.30089340 |
| 130 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.29689478 |
| 131 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.29059845 |
| 132 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.28623582 |
| 133 | Alcoholism_Homo sapiens_hsa05034 | 0.27858892 |
| 134 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.27444050 |
| 135 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.26550596 |
| 136 | Apoptosis_Homo sapiens_hsa04210 | 0.25738642 |
| 137 | Phototransduction_Homo sapiens_hsa04744 | 0.25258846 |
| 138 | HTLV-I infection_Homo sapiens_hsa05166 | 0.24878134 |
| 139 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.23824295 |
| 140 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.23164857 |
| 141 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.20556687 |
| 142 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.20485368 |
| 143 | Leishmaniasis_Homo sapiens_hsa05140 | 0.20444371 |
| 144 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.18274177 |
| 145 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.18057342 |
| 146 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.17096790 |
| 147 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.16488557 |
| 148 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.15597420 |
| 149 | Phagosome_Homo sapiens_hsa04145 | 0.15597056 |
| 150 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.15051150 |
| 151 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.14845115 |
| 152 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.14627950 |
| 153 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.14180056 |

